Diamine Oxidase Enzyme

Global Diamine Oxidase Enzyme Market to Reach US$29.3 Million by 2030

The global market for Diamine Oxidase Enzyme estimated at US$22.6 Million in the year 2024, is expected to reach US$29.3 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Liquid Diamine Oxidase Enzyme, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.4 Million by the end of the analysis period. Growth in the Powder Diamine Oxidase Enzyme segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.2 Million While China is Forecast to Grow at 8.1% CAGR

The Diamine Oxidase Enzyme market in the U.S. is estimated at US$6.2 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.1 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Diamine Oxidase Enzyme Market – Key Trends & Drivers Summarized

Why Is the Demand for Diamine Oxidase (DAO) Enzyme Increasing?

Diamine oxidase (DAO) is a critical enzyme responsible for breaking down histamine in the human body, playing a vital role in preventing histamine intolerance-related disorders. With growing awareness of histamine intolerance, which manifests as migraines, gastrointestinal distress, and allergic reactions, the demand for DAO supplements and enzyme-based therapeutics has surged. Many individuals suffer from reduced DAO activity due to genetic predisposition, gut disorders, or medication-induced inhibition, prompting increased reliance on exogenous DAO supplementation. The rising prevalence of food allergies, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD) has further driven interest in DAO-based therapies. Additionally, the food and beverage industry is exploring DAO applications in histamine-reducing products, particularly in aged foods like wine, cheese, and fermented products, which are known to contain high histamine levels. The growing consumer preference for enzyme-based natural health solutions over pharmaceutical antihistamines is another factor boosting the market expansion.

What Are the Latest Innovations in Diamine Oxidase-Based Therapeutics?

Recent advancements in enzyme biotechnology have led to the development of more effective DAO formulations, including enteric-coated capsules, sublingual sprays, and microencapsulated enzyme systems that enhance bioavailability. These innovations ensure that the enzyme remains stable and active until it reaches the intestine, where histamine breakdown occurs. Additionally, the integration of DAO with prebiotics and probiotics is emerging as a promising approach to restore gut health and improve histamine metabolism. Research into genetically modified DAO enzymes with enhanced stability and efficiency is also gaining traction, potentially expanding therapeutic applications. Pharmaceutical companies are investing in clinical trials to explore DAO’s role in managing migraines, fibromyalgia, and chronic fatigue syndrome, conditions often linked to histamine intolerance. As enzyme engineering continues to advance, DAO supplements and therapeutics are expected to become more potent, targeted, and accessible to a broader consumer base.

How Is Consumer Awareness and Market Accessibility Driving Growth?

The increasing consumer awareness of histamine intolerance and its associated health impacts has significantly contributed to the rising adoption of DAO supplements. The availability of over-the-counter DAO enzyme products in pharmacies, online platforms, and specialty health stores has improved accessibility, making it easier for individuals to manage histamine-related symptoms. The rise of self-diagnosis through online health resources and social media has further fueled consumer demand, prompting manufacturers to expand product lines and improve formulation transparency. Additionally, healthcare practitioners, particularly those in functional medicine and integrative health sectors, are recommending DAO supplementation as part of personalized treatment plans for patients with gut and immune system disorders. As research continues to validate the benefits of DAO therapy, regulatory approvals for pharmaceutical-grade DAO formulations are expected to drive further adoption, expanding the enzyme’s role beyond the dietary supplement sector.

What Are the Key Factors Driving the Diamine Oxidase Enzyme Market Growth?

The growth in the diamine oxidase enzyme market is driven by several factors, including the rising prevalence of histamine intolerance, increasing consumer preference for natural enzyme-based therapies, and advancements in enzyme stabilization technologies. The growing recognition of DAO’s role in managing gastrointestinal and neurological disorders has fueled demand in both the pharmaceutical and nutraceutical sectors. Additionally, the expansion of functional food and beverage applications, particularly in histamine-reducing food formulations, is creating new market opportunities. The increasing use of DAO in gut health supplements and personalized nutrition programs is also driving market adoption. Furthermore, advancements in enzyme engineering and biofermentation technologies are improving the efficiency and scalability of DAO production, making it more affordable and accessible. With ongoing research and regulatory developments supporting the therapeutic potential of DAO, the market is set for sustained growth, catering to a wide range of health-conscious consumers and patients seeking targeted enzyme-based solutions.

SCOPE OF STUDY:

The report analyzes the Diamine Oxidase Enzyme market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Form (Liquid Diamine Oxidase Enzyme, Powder Diamine Oxidase Enzyme, Capsule Diamine Oxidase Enzyme, Tablet Diamine Oxidase Enzyme, Other Forms); Distribution Channel (Pharmacies and Drugstores Distribution Channel, Health Food Stores Distribution Channel, Online Retailers Distribution Channel, Other Distribution Channels); Application (Food and Beverage Application, Healthcare and Pharmaceuticals Application, Industrial Application, Cosmetics and Personal Care Application, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• AB Biotek
• AMS Biotechnology (Europe) Ltd. (amsbio)
• Bioiberica SAU
• Biogena GmbH & Co KG
• Creative Enzymes
• DR Healthcare España, S.L.U.
• Eat All (Stada Group)
• Enzymedica, Inc.
• Jarrow Formulas, Inc.
• Kirkman Group, Inc.
• Klaire Labs
• NaturDAO
• Nature`s Way
• NOW Foods
• Pure Encapsulations, LLC
• Seeking Health, LLC
• Solgar, Inc.
• Swanson Health Products
• Xymogen

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.